{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:26:44Z","timestamp":1767968804023,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>SARS-CoV-2 infection can present with a broad clinical differential that includes many other respiratory viruses; therefore, accurate tests are crucial to distinguish true COVID-19 cases from pathogens that do not require urgent public health interventions. Co-circulation of other respiratory viruses is largely unknown during the COVID-19 pandemic but would inform strategies to rapidly and accurately test patients with respiratory symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study retrospectively examined 298,415 respiratory specimens collected from symptomatic patients for SARS-CoV-2 testing in the three months since COVID-19 was initially documented in the province of Alberta, Canada (March-May, 2020). By focusing on 52,285 specimens that were also tested with the Luminex <jats:italic>Respiratory Pathogen Panel<\/jats:italic> for 17 other pathogens, this study examines the prevalence of 18 potentially co-circulating pathogens and their relative rates in prior years versus since COVID-19 emerged, including four endemic coronaviruses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SARS-CoV-2 was identified in 2.2% of all specimens. Parallel broad multiplex testing detected additional pathogens in only 3.4% of these SARS-CoV-2-positive specimens: significantly less than in SARS-CoV-2-negative specimens (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), suggesting very low rates of SARS-CoV-2 co-infection. Furthermore, the overall co-infection rate was significantly lower among specimens with SARS-CoV-2 detected (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Finally, less than 0.005% of all specimens tested positive for both SARS-CoV-2 and any of the four endemic coronaviruses tested, strongly suggesting neither co-infection nor cross-reactivity between these coronaviruses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Broad respiratory pathogen testing rarely detected additional pathogens in SARS-CoV-2-positive specimens. While helpful to understand co-circulation of respiratory viruses causing similar symptoms as COVID-19, ultimately these broad tests were resource-intensive and inflexible in a time when clinical laboratories face unprecedented demand for respiratory virus testing, with further increases expected during influenza season. A transition from broad, multiplex tests toward streamlined diagnostic algorithms targeting respiratory pathogens of public health concern could simultaneously reduce the overall burden on clinical laboratories while prioritizing testing of pathogens of public health importance. This is particularly valuable with ongoing strains on testing resources, exacerbated during influenza seasons.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-021-01545-9","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:09:32Z","timestamp":1620043772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0303-7226","authenticated-orcid":false,"given":"Natalie C.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3428-1766","authenticated-orcid":false,"given":"Ruwandi M.","family":"Kariyawasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0052-8203","authenticated-orcid":false,"given":"Nathan","family":"Zelyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-6807","authenticated-orcid":false,"given":"Jamil N.","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-0686","authenticated-orcid":false,"given":"Mathew A.","family":"Diggle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"1545_CR1","unstructured":"WHO. COVID-19 Weekly epidemiological update. 2020."},{"key":"1545_CR2","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/v4112754","volume":"4","author":"S Fathima","year":"2012","unstructured":"Fathima S, Lee BE, May-Hadford J, Mukhi S, Drews SJ. Use of an innovative web-based laboratory surveillance platform to analyze mixed infections between human metapneumovirus (hMPV) and other respiratory viruses circulating in Alberta (AB), Canada (2009\u20132012). Viruses. 2012;4:2754\u201365.","journal-title":"Viruses"},{"key":"1545_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/infdis\/jiaa185","volume":"222","author":"S Nickbakhsh","year":"2020","unstructured":"Nickbakhsh S, Ho A, Marques DFP, McMenamin J, Gunson RN, Murcia PR. Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. J Infect Dis. 2020;222:17\u201325.","journal-title":"J Infect Dis"},{"key":"1545_CR4","doi-asserted-by":"crossref","unstructured":"Masse S, Capai L, Villechenaud N, Blanchon T, Charrel R, Falchi A. Epidemiology and clinical symptoms related to seasonal coronavirus identified in patients with acute respiratory infections consulting in primary care over six influenza seasons (2014\u20132020) in France. Viruses. MDPI AG; 2020;12.","DOI":"10.3390\/v12060630"},{"key":"1545_CR5","doi-asserted-by":"crossref","unstructured":"Bastien N, Anderson K, Hart L, Van Caeseele P, Brandt K, Milley D, et al. Human coronavirus NL63 infection in Canada. J Infect Dis. Oxford University Press (OUP); 2005;191:503\u20136.","DOI":"10.1086\/426869"},{"key":"1545_CR6","doi-asserted-by":"crossref","unstructured":"Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. J Am Med Assoc. American Medical Association; 2020;323:2085\u20136.","DOI":"10.1001\/jama.2020.6266"},{"key":"1545_CR7","doi-asserted-by":"crossref","unstructured":"Zhang D, Acree ME, Ridgway JP, Shah N, Hazra A, Ravichandran U, et al. Characterizing coinfection in children with COVID-19: a dual center retrospective analysis. Infection Control & Hospital Epidemiology. Cambridge University Press; 2020;1\u20137.","DOI":"10.1017\/ice.2020.1221"},{"key":"1545_CR8","doi-asserted-by":"crossref","unstructured":"Hazra A, Collison M, Pisano J, Kumar M, Oehler C, Ridgway J. Co-infections with SARS-CoV-2 and other respiratory pathogens. Infection Control and Hospital Epidemiology. Cambridge University Press; 2020;41.","DOI":"10.1017\/ice.2020.322"},{"key":"1545_CR9","doi-asserted-by":"crossref","unstructured":"Sanchez-Nadales A, Treminio-Quezada M, Abad H, Navarro-Motta J, Contreras-Chavez P, Kachru A, et al. Critical care management for novel 2019 SARS-CoV-2 and HCoV-NL63 coinfection in a young immunocompromised patient: a Chicago experience. Case Reports in Critical Care. Hindawi Limited; 2020;2020:1\u20138.","DOI":"10.1155\/2020\/8877641"},{"key":"1545_CR10","doi-asserted-by":"crossref","unstructured":"Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE. Co-infection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus\/enterovirus? J Med Virol. 2020;","DOI":"10.1002\/jmv.25953"},{"key":"1545_CR11","doi-asserted-by":"crossref","unstructured":"Lin D, Liu L, Zhang M, Hu Y, Yang Q, Guo J, et al. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients. Science China Life Sciences. Science in China Press; 2020;63:606\u20139.","DOI":"10.1007\/s11427-020-1668-5"},{"key":"1545_CR12","doi-asserted-by":"crossref","unstructured":"Castillo EM, Coyne CJ, Brennan JJ, Tomaszewski CA. Rates of coinfection with other respiratory pathogens in patients positive for coronavirus disease 2019 (COVID\u201019). Journal of the American College of Emergency Physicians Open. Wiley; 2020;1:592\u20136.","DOI":"10.1002\/emp2.12172"},{"key":"1545_CR13","doi-asserted-by":"crossref","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. Journal of Infection. W.B. Saunders Ltd; 2020;81:266\u201375.","DOI":"10.1016\/j.jinf.2020.05.046"},{"key":"1545_CR14","doi-asserted-by":"crossref","unstructured":"Greninger AL, Jerome KR. The first quarter of SARS-CoV-2 testing: The university of Washington medicine experience. Journal of Clinical Microbiology. American Society for Microbiology; 2020;58.","DOI":"10.1128\/JCM.01416-20"},{"key":"1545_CR15","doi-asserted-by":"crossref","unstructured":"Pettengill MA, McAdam AJ. Can we test our way out of the COVID-19 pandemic? J Clin Microbiol. American Society for Microbiology Journals; 2020.","DOI":"10.1128\/JCM.02225-20"},{"key":"1545_CR16","doi-asserted-by":"crossref","unstructured":"Binnicker MJ. Challenges and controversies related to testing for COVID-19. J Clin Microbiol. American Society for Microbiology; 2020.","DOI":"10.1128\/JCM.01695-20"},{"key":"1545_CR17","doi-asserted-by":"crossref","unstructured":"Pabbaraju K, Wong AA, Douesnard M, Ma R, Gill K, Dieu P, et al. A public health laboratory response to the pandemic. J Clin Microbiol. American Society for Microbiology; 2020;58.","DOI":"10.1128\/JCM.01110-20"},{"key":"1545_CR18","doi-asserted-by":"crossref","unstructured":"Pabbaraju K, Wong A, Douesnard M, Ma R, Gill K, Dieu P, et al. Development and validation of reverse transcriptase-PCR assays for the testing of SARS-CoV-2. J Assoc Med Microbiol Infect Dis Canada; 2021; e20200026.","DOI":"10.3138\/jammi-2020-0026"},{"key":"1545_CR19","unstructured":"Roche. Considerations for laboratories investigating manual pooling of patient samples using the cobas SARS-CoV-2 assay on the cobas 6800\/8800 systems. 2020 Apr."},{"key":"1545_CR20","unstructured":"Seegene. Summary of Allplex TM 2019-nCoV Assay performance data. Seegene. 2020."},{"key":"1545_CR21","unstructured":"Simplexa. Simplexa\u00ae COVID-19 Direct Kit. 2020."},{"key":"1545_CR22","unstructured":"GeneXpert. Xpert\u00ae Xpress SARS-CoV-2 Package Insert. 2020."},{"key":"1545_CR23","unstructured":"Retrospective testing of respiratory specimens for COVID-19 to assess for earlier SARS-CoV-2 infections in Alberta, Canada. Journal of the Association of Medical Microbiology and Infectious Disease Canada."},{"key":"1545_CR24","unstructured":"Huang ACC, Huang CG, Yang CT, Hu HC. Concomitant infection with COVID-19 and Mycoplasma pneumoniae. Biomed J. Elsevier B.V.; 2020;20:30100\u20131."},{"key":"1545_CR25","doi-asserted-by":"crossref","unstructured":"Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D\u2019Andria M, et al. Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature. Infection. Springer; 2020.","DOI":"10.21203\/rs.3.rs-37532\/v1"},{"key":"1545_CR26","doi-asserted-by":"crossref","unstructured":"Gayam V, Konala VM, Naramala S, Garlapati PR, Merghani MA, Regmi N, et al. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J Med Virol. John Wiley and Sons Inc.; 2020;92:2181\u20137.","DOI":"10.1002\/jmv.26026"},{"key":"1545_CR27","doi-asserted-by":"crossref","unstructured":"Monte Serrano J, Garc\u00eda-Gil MF, Crua\u00f1es Monferrer J, Aldea Manrique B, Prieto-Torres L, Garc\u00eda Garc\u00eda M, et al. COVID-19 and Mycoplasma pneumoniae: SARS-CoV-2 false positive or coinfection? Int J Dermatol. Blackwell Publishing Ltd; 2020;","DOI":"10.1111\/ijd.15090"},{"key":"1545_CR28","doi-asserted-by":"crossref","unstructured":"Sagar M, Reifler K, Rossi M, Miller NS, Sinha P, White L, et al. Recent endemic coronavirus infection is associated with less severe COVID-19. Journal of Clinical Investigation. American Society for Clinical Investigation; 2020.","DOI":"10.1172\/JCI143380"},{"key":"1545_CR29","doi-asserted-by":"crossref","unstructured":"Killerby ME, Biggs HM, Haynes A, Dahl RM, Mustaquim D, Gerber SI, et al. Human coronavirus circulation in the United States 2014\u20132017. J Clin Virol. Elsevier B.V.; 2018;101:52\u20136.","DOI":"10.1016\/j.jcv.2018.01.019"},{"key":"1545_CR30","doi-asserted-by":"crossref","unstructured":"Rogers R, O\u2019Brien T, Aridi J, Beckwith CG. The COVID-19 diagnostic dilemma: a clinician\u2019s perspective. J Clin Microbiol. American Society for Microbiology; 2020;58.","DOI":"10.1128\/JCM.01287-20"},{"key":"1545_CR31","doi-asserted-by":"crossref","unstructured":"Hanson KE, Barker AP, Hillyard DR, Gilmore N, Barrett JW, Orlandi RR, et al. Self-collected anterior nasal and saliva specimens versus healthcare worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2. J Clin Microbiol. American Society for Microbiology; 2020.","DOI":"10.1101\/2020.07.17.20155754"},{"key":"1545_CR32","doi-asserted-by":"crossref","unstructured":"Moreno-Contreras J, Espinoza MA, Sandoval-Jaime C, Cant\u00fa-Cuevas MA, Bar\u00f3n-Olivares H, Ortiz-Orozco OD, et al. Saliva sampling and its direct lysis, an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supply shortages. J Clin Microbiol. American Society for Microbiology; 2020;58.","DOI":"10.1128\/JCM.01659-20"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-021-01545-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T06:12:21Z","timestamp":1626847941000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01545-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1545"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01545-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Alberta Health Research Ethics Board (Pro00105658), which operates in compliance with the Canadian 2014 Tri-Council Policy Statement: Ethical Conduct for Research Involving Human Participants, the International Conference on Harmonization (ICH) E6, Good Clinical Practice (GCP), Part C Division 5 of the Canadian Food and Drug Regulations, and the Canadian General Standards Board (CGSB 191.1 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}